FOR IMMEDIATE RELEASE
MESA, Ariz. — August 16, 2025
The Marchand Institute is thrilled to be back in EJOG this month with our newest publication on the latest generation of MIGS Techniques. This paper looks into new techniques, including miniature and single port techniques. The paper is called : “Comparative efficacy and safety of newest generation minimally invasive techniques in hysterectomy: A meta-analysis of miniature laparoscopy versus single-port laparoscopy.” You can find the full text online available here for a limited time: https://authors.elsevier.com/c/1lbxs14VD5yqxX
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###